Improve the Patients' Recovery With Family- Caregivers to End Delirium

Delirium Clinical Trial

— iPREPARED  

Official title:

Improve the Patients' Recovery by Engagement and Partnerships With Family- CaregiveRs to End Delirium (iPREPARED) - A Feasibility and Acceptability Study

Clinical Trial Details — Status: Suspended

Administrative data

• NCT number: NCT05118867
• Other study ID #: 21-005022
• Status: Suspended
• Phase: N/A
• Start date: December 16, 2021
• Est. completion date: December 2024

Study information

• Verified date: March 2024
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This research is being done to find out if patients and caregivers who use the iPREPARED mobile health technology experience less delirium, a type of acute confusion, and if they do experience delirium, the delirium will be less severe and distressful.

iPREPARED prepares patients and caregivers on what to expect during their hospital stay and provides instructions and resources on how to use non-pharmacologic strategies like re-orientation, distraction techniques, and other activities to maintain their brain health during their hospital stay.

Description:

The purpose of this pilot study is to assess the feasibility, acceptability, and preliminary efficacy of the iPREPARED mobile health technology to reduce delirium incidence in a two-group, pilot randomized- controlled clinical trial. In the context of this intervention, the caregiver is defined as a patient-identified family member or friend that can accompany the patient in their hospital journey.

Aim 1: Determine the feasibility, acceptability, and usability of the iPREPARED intervention for use by older hospitalized adults (>60yo) and their caregivers (patient-caregiver dyad).

Aim 2: To estimate the effect size needed to reduce the incidence of delirium in participants using the iPREPARED intervention.

Aim 3: Identify patient-caregiver reported strategies to improve the usability of the iPREPARED intervention.

Secondary Outcomes:

1. Association between delirium incidence and self-rated health status (GSRH).

2. Association between delirium incidence, severity, and delirium-related distress (NCCN Distress thermometer) and resiliency (BRS resiliency scale).

3. Acute stress measured by the IPAT will be compared across the two groups. Acute stress measured by the Intensive Care Psychological Assessment Tool (IPAT) will be less in the intervention group.

4. Delirium-related distress will be analyzed across the two groups. Delirium-related distress measured by the NCCN Distress Thermometer will be less in the intervention group.

5. Plasma and serum biomarker differences between groups and between delirium/non- delirium cohort.

6. Clinical outcomes including adverse hospital events (falls, nosocomial infections, aspirations), length of hospital stay, discharge disposition, mortality and 30-day readmission rates will be collected and examined between groups:

1. Nosocomial infection is defined as a diagnosis not present on admission and occurred after 48 hours of hospital admission and includes UTI, Pneumonia, Decub ulcers, Cellulitis, CAUTI's and CLABSI's

Recruitment information / eligibility

• Status: Suspended
• Enrollment: 120
• Est. completion date: December 2024
• Est. primary completion date: December 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 60 Years and older

Eligibility

Patient Inclusion Criteria:

• 60 years of age or older

• Have 1 risk factor for delirium (pre-existing cognitive impairment, vision/hearing impairment, identified as high risk for falls, illness rated as severe)

• Estimated length of stay of 24 hours or more in hospital

• Have an informal caregiver (18 years of age or older, family member or friend) willing to participate

Patient Exclusion Criteria:

• Patient lacks capacity to consent

• Unable to communicate or participate in study due to language barriers or sensory deficits

• Prisoners

• Documented history of dementia in the medical record

• Patient admitted to hospice service or actively dying

• Delirium present upon admission to hospital

• COVID-19 positive test

Caregiver Inclusion Criteria:

• 18 years of age or older

• Family member, friend, or neighbor of the patient willing to participate in the study and support the patient during the study period (support can be in-person or virtual)

Caregiver Exclusion Criteria:

• Unable or unwilling to participate due to language barriers, availability, or other communication barriers

Related Conditions & MeSH terms

• Delirium

Intervention

Behavioral:
• iPREPARED
iPREPARED is a mobile health technology that can be accessed via the web, tablet, or phone. It contains a preparatory video that outlines what to expect during the hospitalization. Instructional videos and examples are provided for the patient and their recovery partner to use to do their own reorientation, distraction techniques, physical activity, and sleep hygiene.

Locations

Country	Name	City	State
United States	Mayo Clinic in Rochester	Rochester	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feasibility of study recruitment to intervention study	Total number of patient-caregiver dyads enrolled in the study	Number approached for study that were eligible and number consented into study over 2-year study.
Primary	Usability and acceptability of digital technology	Measured using the System Usability Scale and the treatment acceptability preference questionnaire which measure the participants self-reported usability and acceptability of the iPREPARED intervention.	From enrollment through study completion, an average of 4 days
Primary	Delirium incidence	The incidence of delirium will be assessed upon enrollment then twice daily on days 1-4 of the study, and upon hospital discharge using the 3DCAM. Effect sizes between groups will be generated for future larger studies.	From enrollment through study completion, an average of 4 days
Secondary	Delirium-related distress	The NCCN distress thermometer will be used twice daily to assess the level of self-reported distress associated with the signs and symptoms of delirium.	From enrollment through study completion, an average of 4 days
Secondary	Resiliency	Measured using the brief resilience scale that assesses the participants ability to recover from stressful events through 6-item questionnaire asking participants to response to questions on a scale of strongly disagree, disagree, neutral, agree, or strongly agree.	At enrollment into study
Secondary	General Self-Rated Health Status	Measured using the self-reported general self-rated health status (GSRH) asking participants to rate their general health as good, rather good, poor, or very poor.	At enrollment into study
Secondary	Delirium Severity	Delirium severity will be assessed using the Delirium Rating Scale - R- 98 (DRS-R-98). This will be assessed upon enrollment, twice daily on hospital days 1-4, and upon discharge.	From enrollment through study completion, an average of 4 days
Secondary	Acute Stress associated with the hospitalization	The Intensive Care Psychological Assessment Tool (IPAT) will be administered with concurrent delirium incidence and severity measurement.47 This is a 10-item scale that evaluates how a patient has been feeling since their admission. These answers will inform the delirium assessments.	From enrollment through study completion, an average of 4 days
Secondary	Biomarkers	Plasma and serum biomarker differences between groups and between delirium/non-delirium cohort	At enrollment and Day 4
Secondary	Discharge disposition	Place (home, rehabilitation facility, long term care facility) that patient was discharged from the hospital to for continued care.	From enrollment through study completion, an average of 4 days
Secondary	30-day readmission rates	Rate of patients that were re-admitted to the hospital following the index hospitalization	30-days after hospital discharge date
Secondary	Length of hospital stay	Number of days admitted to hospital	From enrollment through study completion, an average of 4 days